The histone deacetylase inhibitor OBP-801 has in vitro/in vivo anti-neuroblastoma activity
{{output}}
Background: Patients with high-risk neuroblastoma have a poor prognosis; new therapeutic agents are therefore required. We investigated the antitumor effects of OBP-801, a novel histone deacetylase inhibitor, its underlying mecha... ...
